Labelling CD63-targeting antibody with Alexa Fluor 647 and anti-HER2 antibody with Alexa Fluor 488 enabled imaging with TIRF and simultaneous dual colour PALM/dSTORM for breast cancer cell line-derived EVs alone, as well as upon interaction with non-cancer cells [106]. This evidence concerns the gene CD63 and cancer.